SO YOUR company’s stock is down – way down from where you think it ought to be and way below its 52-week high. You find yourself fielding calls from any one of the following: irate, disgruntled, or disappointed shareholders. What a distraction! What should you do?

Well for one, be patient, be polite and keep your cool. Remember, many of your shareholders have no experience in a down market and they are hurting.  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.